Investigational COVID-19 Therapeutics To Be Evaluated In Large Clinical Trials
According to a news release, the National Institutes of Health are enrolling participants who have been hospitalized with COVID-19 to evaluate investigation therapeutics in two large clinical trials. Two randomized, controlled Phase 3 clinical trials have begun evaluating investigational monoclonal antibodies for their safety and efficacy in treating people hospitalized with moderate COVID-19. The trials …